Case 36-year old woman. Frequent headaches since age 14, daily headaches for at least 10 years. What to do? Headache diary revealed 16 days with migraine.

Slides:

Advertisements

Similar presentations

Advertisements

Headache Lawrence Pike.

Headache Guideline Cumbria

Headaches - In Primary Care Dr M Banerjee GP Registrar Tadworth.

02/05/20151 HEADACHES; When to seek advice? DR FAYYAZ AHMED CONSULTANT NEUROLOGIST HULL & EAST YORKSHIRE HOSPITALS NHS TRUST.

BACKGROUND Acute pharmacologic treatments for migraine are often switched in clinical practice. Switch studies have typically focused on treatment effects.

Migraine and You An Educational Guide for Migraine Headache Sufferers.

A previous analysis of the AMPP study found that 91.7% of respondents with migraine used acute treatments for headache. Of these respondents18.3% used.

A randomized controlled trial of citalopram on migraine frequency Satnam S. Nijjar, M.D. Department of Neurology, Johns Hopkins School of Medicine.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.

Management of Migraine MIGRAINE - Pattern of recurrent episodes of severe disabling headache associated with nausea and sensitivity to light and who have.

New Study Finds Americans Need 6 Hours Of Sleep At Work.

 Migraine is a benign and recurring syndrome of headache, nausea and vomiting, and /or other neurological dysfunction.  Migraine, the most common cause.

The Cochrane Reviews of Acupuncture Doris Hubbs, MD, FACP April 26, 2013.

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine.

Migraines Mark Green, MD Clinical Professor Department of Neurology Columbia University New York, NY.

48-year-old woman with migraine with aura and menstrual ‘sinus’ headaches Presented by: Anne MacGregor Barts Sexual Health Centre, St. Bartholomew’s Hospital,

Sublingual Buprenorphine and Pain

2008. Diagnostic criteria  At least 10 episodes fulfilling following criteria  Headache lasting 30 mins to 7 days  Has 2 at least 2 of the following.

INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,

What is it? -FM is the inflammation of white fibrous tissues (especially muscle sheaths). - FM is one of the main causes of Chronic Widespread Pain (CWP).

Depression Measures Health Disparities Collaborative 2005.

Oral triptans (serotonin 5-HT 1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials by Michel D. Ferrari, Krista I. Roon, Richard B.

My migraine ruins my weekends CLINICAL CASE Presented by: Julio Pascual Neuroscience Area, Service of Neurology, University Hospital Central de Asturias.

International Classification of Headache Disorders, 2nd ed. ICHD-II & Chronic Migraine Diagnostic Criteria l Chronic migraine: headache (not.

Migraine. What is migraine? MeReC Bulletin 2002; 13: Primary episodic headache disorder.

Diagnosis and management of primary headache

“My migraine always comes back” Presented by: Julio Pascual Neuroscience Area, Service of Neurology, University Hospital Central de Asturias and Ineuropa,

39-year-old woman with ‘monthly’ headaches Presented by: Anne MacGregor Barts Sexual Health Centre, St. Bartholomew’s Hospital, London, UK CLINICAL CASE.

Menstrual Migraine Anne MacGregor

MIGRAINE IN PRIMARY CARE ADVISORS Development of pharmacist guidelines for migraine management.

Serious Causes Rarely seen, but not to be missed.

School of Clinical Medicine School of Clinical Medicine UNIVERSITY OF CAMBRIDGE Headache Jane Smith, a 23 year old woman, presents to her GP complaining.

INCREASED INCIDENCE OF REBOUND HEADACHES FROM THE DISCONTINUED USE OF THE ANTI-MIGRAINE MEDICATION, MAXALT ® Sherry Neff Department of Biological Sciences,

Stuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth.

4th Biennial Hull-BASH Headache Meeting Jan 20th 2011

Czech headache guidelines for general practitioners Jolana Marková Thomayer University Hospital Prague.

Dr David PB Watson GPwSI Hamilton Medical Group Aberdeen

RESPONSE TO ANTIDEPRESSANT MEDICATION, COGNITIVE BEHAVIOR THERAPY AND PLACEBO IN CHRONIC TENSION-TYPE HEADACHE VARIES WITH PSYCHIATRIC COMORBIDITY & HEADACHE.

Migraines and Electronic Aspirin

COMOESTAS – Grant agreement no Final Conference, Buenos Aires, November 26 th, THE COMOESTAS PROJECT Round Table.

 Dr David PB Watson  Aberdeen.  Background Information  Case Presentation  General Discussion with Qs and As.

Question 1 Pozen estimated an annual incidence of tardive dyskinesia (TD) of up to 0.038% for metoclopramide at a daily dose of mg/day for 72 days/year.

Poster Title Epicranial nerves blocks in the treatment of chronic migraine Caputi Claudio A., Firetto Vincenzo Caputi Claudio A., Firetto Vincenzo Medicina.

COMOESTAS – Grant agreement no Pre-Review meeting, Buenos Aires, November 27th, The principal results of the project WP5 A and WP5B Rigmor.

جامعة الكوفه مركز تطوير التدريس والتدريب الجامعي Tention Headache اعداد د. محمد راضي رديف بورد طب جمله عصبيه كلية الطب – جامعة الكوفه 2015 م.

Dublin November 13 th 2011 By Dr. Edward O’Sullivan 13-Nov

CLINICAL TIPS AND PEARLS. Clinical Tips and Pearls The more diagnoses made, the more medications tried, the more likely it is MOH. – When in doubt for.

Dr. Rupak Sethuraman. SPECIFIC LEARNING OBJECTIVES Various management techniques of orofacial pain Management of common orofacial pain disorders.

How to Manage Recurrent Headache Allan Gordon MD, FRCP(C) Neurologist and Director Wasser Pain Management Centre John and Josie Watson Pain Education and.

FREQUENTLY ASKED QUESTIONS. Frequently Asked Questions Should mono- or polytherapy be used for acute treatment of migraine? Should mono- or polytherapy.

Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.

Denis G. Patterson, DO Nevada Advanced Pain Specialists Contact Information.

The Use of Topiramate to Prevent Pediatric Migraine Headaches: A Systematic Review Tammy Wilson, PA-S Pacific University School of Physician Assistant.

Managing Migraine. Firstly is the Diagnosis correct? Worrying features: Worsening headache with fever Rapid onset (previously referred to as 'thunder.

Assoc. Prof. Martin Valis, M.D., Ph.D.

Methods Subjects: yo w migraine wwo aura (defined by ICHD3beta) for at least 1yr ≥4 and

why we need new therapeutic approaches

Frequently asked questions

Clinical cases.

Seizures in the Elderly: Treatment and Special Considerations

Proportion of Patients Achieving a ≥30% Reduction in Pain Scores at Week 12 of Stable Dose Treatment

Clinical tips and pearls

INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,

INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,

Headache Lawrence Pike.

Dr sadik al ghazawi Associated professer Neurologist Mrcp,frcp uk

Diagnostic Criteria Migraine Without Aura

Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.

Therapy of the Acute Migraine Attack. Therapy of the Migraine Attack Criteria for efficacy Pain free after 2 hrs Improvement of headache from severe.

Presentation transcript:

Case 36-year old woman. Frequent headaches since age 14, daily headaches for at least 10 years. What to do? Headache diary revealed 16 days with migraine and 14 days with tension-type headache per month. Diagnosis? Chronic daily headache? Migraine and tension-type headache? Chronic migraine? Chronic migraine and medication-overuse headache?

Medication-overuse headache ICHD-III beta, 2013 A.Headache occurring on ≥15 days/month in a patient with a pre-existing headache disorder B.Regular overuse for >3 months of one or more drugs 1 that can be taken for acute and/or symptomatic treatment of headaches C.Not better accounted for by another ICHD-3 diagnosis Note 1 A. Ergotamine, triptans, opioids, combination analgesics or any combination of analgesics on ≥10 days/month B. Simple analgesics or NSAIDs on ≥15 days/month

Case Headache diary also revealed daily intake of NSAIDs and intake of triptans 12 days per month Diagnosis: Chronic migraine and medication-overuse headache What to do? Withdraw NSAIDs and triptans

Case

Central sensitization in MOH is reverted after detoxification Lower pain thresholds in MOH than healthy controls (p<0.05) Supra-threshold pain scores –Extra-cephalic: no significant difference –Cephalic MOH patients > healthy controls (p<0.05) 6 months and 12 months < baseline (p<0.05) Healthy controls MOH baseline MOH 2 months MOH 6 months MOH 12 months Munksgaard, Bendtsen and Jensen, Cephalalgia 2013

Management of MOH in a tertiary headache center 98 refractory MOH patients 90% completed withdrawal and 88% completed follow-up 83% without MOH at 1-year follow-up (cured of MOH) 39% reduction in headache frequency (p<0.001) 60% episodic headache 49% responders Munksgaard, Bendtsen and Jensen, Cephalagia 2012 Days/month

Medication-overuse headache Efficacy of detoxification and prophylaxis demonstrated in several individual centers Most experts recommend that withdrawal therapy should be offered (Evers and Marziniak, Lancet Neurology 2010) Some recommend Botox therapy (Dodick et al., Headache 2010) Some recommend topiramate therapy (Silberstein et al., Headache 2009)

Medication-overuse headache Percentage of patients seen in headache centers having MOH US more than 50% Chile 55% Argentina 70% MOH is very common in specialized headache centers

Treatment of medication-overuse headache Take home messages Always consider MOH in patients with chronic headache Use calendar to monitor intake of analgesics during treatment Educate and prevent Detoxification and prophylactic treatment is highly effective in reducing headache days, disability, depression, anxiety and costs